CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver

作者: H. Kuniyasu , Y. Luo , K. Fujii , T. Sasahira , Y. Moriwaka

DOI: 10.1136/GUT.2009.178376

关键词: Epidermal growth factor receptorReceptorCancer researchCancerHT29 CellsApoptosisCell growthThiorphanPathologyMetastasisMedicine

摘要: Objective: To examine the role of CD10, a characteristic marker liver metastasis colorectal cancers (CRCs). Design: The effect CD10 and Met-enkephalin (MENK) in CD10-positive -negative human CRC cells was investigated under vitro vivo conditions. Human samples were examined. Main outcome measure: CD10-knockdown HT29 CD10-negative CD10-transfected Colo320 nude mice treated with MENK and/or inhibitor (thiorphan). Intracellular signaling ƒO-opioid receptor (DOR) examined by immunoblotting. Results: inhibited growth, invasion, survival following thiorphan-induced inactivation. Thiorphan suppressed cells. Inoculation induced expression liver. Inhibition hepatic cholesterol-conjugated antisense S-oligodeoxynucleotide increased even when did not express CD10. DOR activation decreased phosphorylation epidermal growth factor extracellular signal-regulated kinase p38-dependent apoptosis. Nitric oxide found to induce Co-treatment thiorphan nitric donor had marked antitumor on Of 68 patients, 19 (28%) showed expression, which dependent extent metastasis. concentration metastasis-positive higher than that normal Conclusion: abrogates degrading it, enhances

参考文章(42)
Belowski D, Madej A, Herman Zs, Kowalski J, Antitumor activity of bestatin and thiorphan in mice. Archivum Immunologiae Et Therapiae Experimentalis. ,vol. 43, pp. 265- ,(1995)
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
H Kenneth Kramer, Irma Onoprishvili, Matthew L Andria, Kayane Hanna, Karina Sheinkman, Lisa B Haddad, Eric J Simon, Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases. BMC Pharmacology. ,vol. 2, pp. 5- 5 ,(2002) , 10.1186/1471-2210-2-5
I. S. Zagon, S. D. Hytrek, P. J. McLaughlin, Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 271, ,(1996) , 10.1152/AJPREGU.1996.271.3.R511
G Patey, S De La Baume, J. Schwartz, C Gros, B Roques, M. Fournie-Zaluski, E Soroca-Lucas, Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition. Science. ,vol. 212, pp. 1153- 1155 ,(1981) , 10.1126/SCIENCE.7015510
Aydan Eroğlu, Aliye Sari, Expression of c-kit proto-oncogene product in breast cancer tissues. Medical Oncology. ,vol. 24, pp. 169- 174 ,(2007) , 10.1007/BF02698036
M. A. Shipp, J. Vijayaraghavan, E. V. Schmidt, E. L. Masteller, L. D'Adamio, L. B. Hersh, E. L. Reinherz, Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 (enkephalinase): direct evidence by cDNA transfection analysis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 86, pp. 297- 301 ,(1989) , 10.1073/PNAS.86.1.297
Yulong L. Chen, Ping-Yee Law, Horace H. Loh, Action of NF-κB on the delta opioid receptor gene promoter Biochemical and Biophysical Research Communications. ,vol. 352, pp. 818- 822 ,(2007) , 10.1016/J.BBRC.2006.11.103
Yutaka Ohji, Takashi Yao, Takashi Eguchi, Tomomi Yamada, Minako Hirahashi, Mitsuo Iida, Masazumi Tsuneyoshi, Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors. Oncology Reports. ,vol. 17, pp. 525- 530 ,(2007) , 10.3892/OR.17.3.525
Rüdiger Schulz, Daniela A. Eisinger, Andrea Wehmeyer, Opioid control of MAP kinase cascade European Journal of Pharmacology. ,vol. 500, pp. 487- 497 ,(2004) , 10.1016/J.EJPHAR.2004.07.010